Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Barbara Ryan Insider Profile
4 Followers
Barbara Ryan, Director at NAYA Biosciences, holds 150.34K shares in MiNK Therapeutics (Ticker: INKT), holds 22.99K shares in NAYA Biosciences (Ticker: NAYA), holds ― shares in Azitra Inc (Ticker: AZTR).
Barbara Ryan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Barbara Ryan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Barbara Ryan
Barbara Ryan's Trading History
NAYA Biosciences
Jun 03, 2022
Director
Informative Buy
10.00K
$17.24K
MiNK Therapeutics
Dec 03, 2024
Director
Uninformative Buy
17.69K
$78.78K
Azitra Inc
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Barbara Ryan's performance on stock
You May Also Like
Barbara Ryan insider profile FAQ
What is the percentage of profitable transactions made by Barbara Ryan?
The percentage of profitable transactions made by Barbara Ryan is ―.
What is the average return per transaction made by Barbara Ryan?
The average return per transaction made by Barbara Ryan is ―.
What stocks does Barbara Ryan hold?
Barbara Ryan holds: NAYA, INKT, AZTR stocks.
What was Barbara Ryan’s latest transaction?
Barbara Ryan latest transaction was an Uninformative Buy of $17.69K.
What was Barbara Ryan's most profitable transaction?
Barbara Ryan’s most profitable transaction was an Informative Buy of NAYA stock on June 3, 2022. The return on the trade was -76.40%.
What is Barbara Ryan's role in NAYA Biosciences?
Barbara Ryan's role in NAYA Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.